Evidence map›Paper›PMID 28005484›Full record

ArticlePublic health reports (Washington, D.C. : 1974)

State Health Department Requirements for Reporting of Antibiotic-Resistant Infections by Providers, United States, 2013 and 2015.

Monika Pogorzelska-Maziarz, Eileen J Carter, Mary Lou Manning, Elaine L Larson

Abstract read
In one paragraph

Article in Public health reports (Washington, D.C. : 1974). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. An outbreak of Panton-Valentine leucocidin-producing meticillin-resistantEuro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Monika Pogorzelska-Maziarz1 Jefferson College of Nursing, Thomas Jefferson University, Philadelphia, PA, USA.
Eileen J Carter2 Columbia University School of Nursing, New York, NY, USA.
Mary Lou Manning1 Jefferson College of Nursing, Thomas Jefferson University, Philadelphia, PA, USA.
Elaine L Larson2 Columbia University School of Nursing, New York, NY, USA.

Funding

Prevention of Nosocomial Infections and Cost-Effectiveness Refined (P-NICER)R01NR010107 · NINR · COLUMBIA UNIVERSITY HEALTH SCIENCES · PI STONE, PATRICIA W. · 2007 to 2012
$3.2M
NINR NIH HHS R01 NR010107
6 · The paper itself

Abstract

Due to the high burden of antibiotic-resistant infections, several US states mandate public reporting of these infections. To examine the extent to which state departments of health require reporting of antibiotic-resistant infections, we abstracted data from lists of reportable conditions from all 50 states at 2 time points, May 2013 and May 2015. Requirements varied substantially by state. In 2015, most states (n = 44) required reporting of at least 1 antibiotic-resistant infection; vancomycin-intermediate and/or vancomycin-resistant Staphylococcus aureus was the most frequently reportable infection (n = 40). Few states required reporting of methicillin-resistant S aureus (n = 11), multidrug-resistant gram-negative bacteria (n = 9), or vancomycin-resistant enterococci (n = 8). During the 2 years we studied, 2013 and 2015, 4 states removed and 9 added at least 1 reporting requirement. The changes in reporting requirements suggest flexibility in health departments' response to local surveillance needs and emerging threats. Future studies should assess how data on antibiotic-resistant infections through different sources are used at the state level to drive prevention and control efforts.

Indexed as

Mandatory ReportingMethicillin ResistancePublic Health AdministrationAnti-Bacterial AgentsCross InfectionHumansMethicillin-Resistant Staphylococcus aureusPopulation SurveillancePractice Patterns, Physicians'United StatesAnti-Bacterial Agentsantibiotic-resistant infectionsnotifiable conditionspublic health reporting

Identifiers

PMID28005484
PMCPMC5298509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.